Forbes 30 Under 30 2017: Science
Mark Smith, 29
Smith’s company, OpenBiome, developed a therapy called fecal microbiota transplantation to treat Clostridium difficile, a common hospital-acquired infection. Like a blood bank for human stool, the nonprofit’s work has helped over 18,000 patients.
Click here for the full profile.